SSRIs: suicide risk and withdrawal – (06-23-03)

SSRIs: suicide risk and withdrawal

Wow. GlaxoSmithkline withheld info from the UK’s regulatory agency when it got approval for paroxetine (Paxil). The study basically showed no increased efficacy over placebo. My question is…this kind of behavior is rampant here in the US as well. How on Earth do these companies not get shut down by the regulatory agencies? Unfortunately, I think we can all guess at the answer.

The Journal : Current Issue

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.

Sign up for Dr. Bogash
Sign up for Dr. Bogash’s Rantings and instantly receive a free copy of his ebook “Dr. Bogash’s Recommendations for Healthy Living”

Email: